Filing Details
- Accession Number:
- 0001485003-17-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-16 17:09:48
- Reporting Period:
- 2017-02-14
- Filing Date:
- 2017-02-16
- Accepted Time:
- 2017-02-16 17:09:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1485003 | Eleven Biotherapeutics Inc. | EBIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1205535 | J John Mccabe | C/O Eleven Biotherapeutics, Inc. 245 First Street, Suite 1800 Cambridge MA 02142 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-02-14 | 1,399 | $2.10 | 5,930 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units.
Billionaire Hedge Funds
